Exploiting Microbiome and Synthetic Biology to Discover and Produce Naturally Occurring Antibiotics
Award amount
$149,877Program and phase
SBIR · Phase IAward year
2016Award details
- Awarding agency
- Department of Defense
- Branch
- Office for Chemical and Biological Defense
- Recipient company
- Radiant Genomics, Inc.
- Proposal award date
- 2016-08-29
- Contract end date
- 2017-02-28
- UEI
- QG8GZKZTMLM6
- Solicitation number
- 2015.2
- Topic code
- CBD152-004
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- A Web Enabled Database for Rapid Metagenomic Biocatalyst Discovery and Validation
- Engineered Actinomycete Production Hosts for Heterologous Natural Product Discovery
- A Metagenomic Platform to Identify Amphotericin B Analogs
- High-throughput SARP-mediated activation of silent gene clusters to produce novel natural products
- A Web-Enabled Database for Rapid Metagenomic Biocatalyst Discovery and Validation
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Producing Novel Biosynthetic Therapeutics from Extreme Microbiomes
- Producing Novel Biosynthetic Therapeutics from Extreme Microbiomes
- Concurrent identification of Natural Antibiotics-Producing Gene Clusters and Culture Conditions
Research funding history
8 SBIR/STTR records share this UEI (2013–2016). Reported award amounts total $3,402,238. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, Department of Defense